CEPI

CEPI awards $16.5M to advance Ebola vaccine into human trials

The Coalition for Epidemic Preparedness Innovations announced Thursday it will provide up to $16.5 million to Egypt-based Minapharm Group to advance an experimental Bundibugyo Ebola vaccine into human trials, as the deadliest Ebola outbreak in Democratic Republic of Congo history…

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna announced Tuesday that it has begun dosing volunteers in the first human trial of mRNA-1469, an experimental vaccine targeting the Bundibugyo strain of Ebola virus — a pathogen with no approved vaccine that is fueling the second-largest Ebola outbreak…

CEPI funds first Bundibugyo Ebola vaccine as Congo outbreak doubles every 20 days

Senior United Nations officials called Wednesday for a three- to five-fold increase in the international response to the Ebola outbreak in eastern Democratic Republic of Congo, warning that the epidemic is doubling in size every 20 days and outpacing containment…

US commits $50M to CEPI for Bundibugyo Ebola countermeasures

The United States announced a $50 million commitment to the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate development of medical countermeasures against the Bundibugyo strain of Ebola virus, as the deadly outbreak in the Democratic Republic of Congo continues…